CORY IPSEN: Open Payments
NPI 1699440958 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 27 payments from 12 companies in 2025. Trend: 2023 $1,067 · 2024 $1,349 · 2025 $784
Food & beverage: $518Education: $266
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $360 |
| ABBVIE INC. | 6 | $128 |
| Janssen Biotech, Inc. | 2 | $71 |
| Antares Pharma, Inc. | 2 | $49 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Endo USA, Inc. | 1 | $23 |
| UROGEN PHARMA, INC. | 1 | $20 |
| Davol Inc. | 1 | $16 |
Products named: BOTOX, Xtandi, ERLEADA, XYOSTED, Bard Urinary Drainage Bag, LUPRON DEPOT, PROVENGE, Nubeqa.
Industry payments across CA — which companies pay providers there.
